Loading...
ASCO Lung Cancer 20172025-01-27T17:44:01+01:00

ASCO 2017 – Chicago

Lecture Board: Martin Filipits, MD; Maximilian Hochmair, MD; Anna Nowak, PhD; Egbert Smit, MD, PhD; Johan Vansteenkiste, MD, PhD;
Yi-Long Wu, MD
Medical Writer: Dr. Judith Moser

DOWNLOADS

All downloads from ASCO 2017

ASCO_2017_Eng

Full report (english)

https://memoinoncology.com/wp-content/uploads/2020/07/memo_InOncology_Special_ASCO_2017_mandarin.pdf

Full report (mandarin)

Full report (japanese)

EXPERT VIDEOS

All video interviews from ASCO 2017

Richard Baird on clinical trial data for treatment of cerebral metastases, including the Cambridge brain mets trial 1 (CamBMT1) phase 1B trial data that he presented at ASCO.

Anna Nowak on malignant mesothelioma: risk factors, prognostic markers, and clinical trial data for mesothelioma treatments to come out of the congress.

Yi-Long Wu, president of the Chinese Society of Clinical Oncology, discusses his society’s collaboration with memo – inOncology, and the approval of afatinib for EGFR+ NSCLC in China.

Maya Gottfried on NSCLC screening and treatment options.

Immunotherapy is an emerging standard in lung cancer management, which is corroborated by the trial updates presented at ASCO 2017, many revealing durable treatment benefit over extended periods. (ASCO 2017)

Anna Nowak • MBBS • FRACP • PhD
Go to Top